← Leaderboards
Stefanie Geisler
Washington University
$2,471,451
Attributed
$2,471,451
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $419.5K · FY2015–25$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,471,451 · 2
By mechanism
R37$1,647,046 · 1
K08$824,405 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Mikhail Y. Berezin$5,444,004
- Sean P. J. Whelan$36,954,740
- Daved H Fremont$19,011,013
- Robert A Davey$11,727,915
- Christopher F Basler$44,557,002
Others in their field
Top investigators on “Neuropathy”
- John M Lachin · George Washington University$140,240,809
- David M Nathan · Massachusetts Institute Of Technology$122,561,681
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Rose A Gubitosi-Klug · Case Western Reserve University$72,618,151
- Marinella Temprosa · George Washington University$50,368,680
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
Research focus
NeuropathyChemotherapeutic AgentTreatment StrategyNeuronsToll-Like ReceptorsVincristinePeripheral Nervous System DiseasesIn VivoPathway InteractionsTranslatingProgramsPreventBehavioralProteinsChemotherapy Induced NeuropathyKnock-OutAxonIn VitroAxonal DegenerationMediatingNeurodegenerative DisordersExperimental StudySide EffectBase
Grant awards (9)
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy$419,407
R37 · FY2025 · CA · contact PI
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy$396,506
R37 · FY2024 · CA · contact PI
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy$411,659
R37 · FY2023 · CA · contact PI
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy$419,474
R37 · FY2022 · CA · contact PI
Sarm1 Pathway: New Therapeutic Targets in Neuropathy$165,529
K08 · FY2019 · NS · contact PI
Sarm1 Pathway: New Therapeutic Targets in Neuropathy$165,529
K08 · FY2018 · NS · contact PI
Sarm1 Pathway: New Therapeutic Targets in Neuropathy$164,449
K08 · FY2017 · NS · contact PI
Sarm1 Pathway: New Therapeutic Targets in Neuropathy$164,449
K08 · FY2016 · NS · contact PI
Sarm1 Pathway: New Therapeutic Targets in Neuropathy$164,449
K08 · FY2015 · NS · contact PI